BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32813957)

  • 1. Serious Ivermectin Toxicity and Human
    Baudou E; Lespine A; Durrieu G; André F; Gandia P; Durand C; Cunat S
    N Engl J Med; 2020 Aug; 383(8):787-789. PubMed ID: 32813957
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-induced eruption after treatment of hyperkeratotic crusted scabies with ivermectin].
    Mara C; Sarrot-Reynauld F; Mallaret M; Raclot-Roy N; Massot C
    Rev Med Interne; 2004 Jun; 25(6):476-7. PubMed ID: 15158324
    [No Abstract]   [Full Text] [Related]  

  • 3. Mazzotti reaction with eosinophilia after undergoing oral ivermectin for scabies.
    Ito T
    J Dermatol; 2013 Sep; 40(9):776-7. PubMed ID: 23855317
    [No Abstract]   [Full Text] [Related]  

  • 4. Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?
    Wilkins AL; Steer AC; Cranswick N; Gwee A
    Arch Dis Child; 2018 May; 103(5):514-519. PubMed ID: 29463522
    [No Abstract]   [Full Text] [Related]  

  • 5. Ivermectin for scabies and headlice: veterinary use only.
    Lowenthal MN
    Isr Med Assoc J; 2013 May; 15(5):262. PubMed ID: 23841255
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness and adverse events of ivermectin treatment for scabies in 30 infant patients: report from a German single centre.
    Ständer S; Kirschstein DJ; Kohl-Sobania M; Zillikens D; Ludwig RJ; Anemüller W
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e736-e737. PubMed ID: 32339346
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Human Scabies with Oral Ivermectin. Eczematous Eruptions as a New Non-Reported Adverse Event.
    Sanz-Navarro J; Feal C; Dauden E
    Actas Dermosifiliogr; 2017 Sep; 108(7):643-649. PubMed ID: 28385424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies.
    Chhaiya SB; Patel VJ; Dave JN; Mehta DS; Shah HA
    Indian J Dermatol Venereol Leprol; 2012; 78(5):605-10. PubMed ID: 22960817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies.
    Ahmad HM; Abdel-Azim ES; Abdel-Aziz RT
    Dermatol Ther; 2016; 29(1):58-63. PubMed ID: 26555785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scabies.
    Johnstone P; Stong M
    Am Fam Physician; 2015 Nov; 92(10):919-20. PubMed ID: 26554285
    [No Abstract]   [Full Text] [Related]  

  • 11. Ivermectin: new indication. Oral treatment of scabies: simple and effective.
    Prescrire Int; 2002 Oct; 11(61):137-40. PubMed ID: 12378743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ivermectin applied topically by whole-body bathing method in healthy volunteers.
    Miyajima A; Hirota T; Tashiro M; Noguchi W; Kawano Y; Hanawa T; Kigure A; Anata T; Yamamoto Y; Yuasa N; Koshino M; Shiraishi Y; Yuzawa K; Akagi K; Yoshimasu T; Makigami K; Komoda M
    J Dermatol; 2017 Apr; 44(4):406-413. PubMed ID: 27743408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-fat meal intake on the pharmacokinetic profile of ivermectin in Japanese patients with scabies.
    Miyajima A; Hirota T; Sugioka A; Fukuzawa M; Sekine M; Yamamoto Y; Yoshimasu T; Kigure A; Anata T; Noguchi W; Akagi K; Komoda M
    J Dermatol; 2016 Sep; 43(9):1030-6. PubMed ID: 26918286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for crusted scabies: limitations and side effects of treatment with ivermectin.
    Fujimoto K; Kawasaki Y; Morimoto K; Kikuchi I; Kawana S
    J Nippon Med Sch; 2014; 81(3):157-63. PubMed ID: 24998962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008106. PubMed ID: 32176703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are the mechanisms associated with post-ivermectin serious adverse events?
    Boussinesq M; Kamgno J; Pion SD; Gardon J
    Trends Parasitol; 2006 Jun; 22(6):244-6. PubMed ID: 16632406
    [No Abstract]   [Full Text] [Related]  

  • 17. Sarcoptic mange in vicuña (Vicugna vicugna) population in Peru.
    Gomez-Puerta LA; Olazabal J; Taylor CE; Cribillero NG; Lopez-Urbina MT; Gonzalez AE
    Vet Rec; 2013 Sep; 173(11):269. PubMed ID: 23893216
    [No Abstract]   [Full Text] [Related]  

  • 18. Ivermectin in dermatology.
    del Giudice P; Chosidow O; Caumes E
    J Drugs Dermatol; 2003 Jan; 2(1):13-21. PubMed ID: 12852376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis after ivermectin.
    Seegobin K; Bueno E; Maharaj S; Ashby T; Brown M; Jones L
    Am J Emerg Med; 2018 May; 36(5):887-889. PubMed ID: 28927997
    [No Abstract]   [Full Text] [Related]  

  • 20. Journal club Update on systemic therapies in paediatric dermatology.
    Mohme S; Alband N; Diaz AR; Lefevre MA; Rodriguez Lomba E; Nogueira M; Goebeler M; Hamm H
    Eur J Dermatol; 2021 Oct; 31(5):672-675. PubMed ID: 34903508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.